Clinical Trials
4 trialsNCT05377905 2026-04-09
cSCC
University of Pittsburgh
Phase 1/2 Recruiting
NCT03969004 2026-03-27
Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma
Regeneron Pharmaceuticals
Phase 3 Active not recruiting
NCT07402616 2026-02-11
Ex Vivo Cutaneous SCC
Rigshospitalet, Denmark
Phase NA Recruiting
NCT04154943 2025-12-23
Study of Cemiplimab in Patients With Type of Skin Cancer Stage II to IV Cutaneous Squamous Cell Carcinoma
Regeneron Pharmaceuticals
Phase 2 Completed